Adjusting Testosterone Therapy for Suboptimal Response
Diagnostic Confirmation and Monitoring
- The American College of Physicians recommends obtaining repeat morning testosterone measurements (8-10 AM) to confirm suboptimal levels, as testosterone exhibits significant diurnal variation and assay variability 2, 1, 3
- Measure both total testosterone and free testosterone by equilibrium dialysis (the most reliable method), along with sex hormone-binding globulin (SHBG) 1, 3
- A total testosterone level of 272 ng/dL is below the 300 ng/dL threshold used to define hypogonadism, and a free testosterone level of 9.4 ng/dL is also suboptimal 2, 1
Dose Adjustment Strategy
- Increase the testosterone dose by one increment based on the current formulation to achieve mid-normal testosterone levels (500-600 ng/dL) measured midway between injections 1
Reassessment Timeline
- Recheck testosterone levels 2-3 months after any dose adjustment to allow steady-state levels to be achieved 1
- For injectable testosterone, measure levels midway between injections, targeting 500-600 ng/dL 1
Formulation Considerations
- Transdermal preparations (gels/patches) may have variable absorption, with gels showing particularly inconsistent testosterone delivery in some patients 1
- Intramuscular injections avoid absorption variability and may be more reliable for patients who appear to be rapid metabolizers 1
Common Pitfalls to Avoid
- Do not assume increased metabolism without confirming suboptimal levels with proper timing (morning, fasting, repeat measurements) 2, 1
- Avoid measuring testosterone at random times of day, as this can lead to misinterpretation 1, 3
Additional Evaluation if Dose Adjustment Fails
- Assess for factors that may lower SHBG and increase testosterone clearance: obesity, insulin resistance, liver disease, hypothyroidism 4
- Consider measuring luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish primary from secondary hypogonadism if not previously done 1, 3